Loading…
Antifungal activity of cinnamic acid derivatives involves inhibition of benzoate 4‐hydroxylase (CYP53)
AIMS: CYP53A15, from the sorghum pathogen Cochliobolus lunatus, is involved in detoxification of benzoate, a key intermediate in aromatic compound metabolism in fungi. Because this enzyme is unique to fungi, it is a promising drug target in fungal pathogens of other eukaryotes. METHODS AND RESULTS:...
Saved in:
Published in: | Journal of applied microbiology 2014-04, Vol.116 (4), p.955-966 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4077-5137232f50ac24147f8a5c340a57ce40f5f28b64821bc267c302dce263c12f33 |
---|---|
cites | cdi_FETCH-LOGICAL-c4077-5137232f50ac24147f8a5c340a57ce40f5f28b64821bc267c302dce263c12f33 |
container_end_page | 966 |
container_issue | 4 |
container_start_page | 955 |
container_title | Journal of applied microbiology |
container_volume | 116 |
creator | Korošec, B Sova, M Turk, S Kraševec, N Novak, M Lah, L Stojan, J Podobnik, B Berne, S Zupanec, N Bunc, M Gobec, S Komel, R |
description | AIMS: CYP53A15, from the sorghum pathogen Cochliobolus lunatus, is involved in detoxification of benzoate, a key intermediate in aromatic compound metabolism in fungi. Because this enzyme is unique to fungi, it is a promising drug target in fungal pathogens of other eukaryotes. METHODS AND RESULTS: In our work, we showed high antifungal activity of seven cinnamic acid derivatives against C. lunatus and two other fungi, Aspergillus niger and Pleurotus ostreatus. To elucidate the mechanism of action of cinnamic acid derivatives with the most potent antifungal properties, we studied the interactions between these compounds and the active site of C. lunatus cytochrome P450, CYP53A15. CONCLUSION: We demonstrated that cinnamic acid and at least four of the 42 tested derivatives inhibit CYP53A15 enzymatic activity. SIGNIFICANCE AND IMPACT OF THE STUDY: By identifying selected derivatives of cinnamic acid as possible antifungal drugs, and CYP53 family enzymes as their targets, we revealed a potential inhibitor‐target system for antifungal drug development. |
doi_str_mv | 10.1111/jam.12417 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1507770560</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3247834631</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4077-5137232f50ac24147f8a5c340a57ce40f5f28b64821bc267c302dce263c12f33</originalsourceid><addsrcrecordid>eNp1kM1OFTEUxxsDEUQXvgBMYkxkMdDvzvbmxg8IRBNx4ao502m5vZnbYjv36rjiEXhGn8TCXGRlNz1pf-f8c34IvSb4hJRzuoTVCaGcqGdonzApaioV3XmoeS2wonvoRc5LjAnDQj5He5QzwqmU-2gxC4N363ANfQVm8Bs_jFV0lfEhwMqb8ui7qrPJb6D82lz5sIn9VCx86wcfw31Da8PvCIOt-J_bu8XYpfhr7CHb6t38-xfBjl-iXQd9tq-29wG6-vD-av6pvvj88Ww-u6gNx0rVgjBFGXUCgykbceUaEIZxDEIZy7ETjjat5A0lrSlrGoZpZyyVzBDqGDtAb6axNyn-WNs86GVcp1ASNSkmlCoCcKGOJ8qkmHOyTt8kv4I0aoL1vVJdlOoHpYU93E5ctyvb_SMfHRbg7RaAbKB3CYLx-YlraMOEbAp3OnE_fW_H_yfq89nlY_TR1OEgarhOZeq3rxSXRXAxI3HD_gKvwZXg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1507770560</pqid></control><display><type>article</type><title>Antifungal activity of cinnamic acid derivatives involves inhibition of benzoate 4‐hydroxylase (CYP53)</title><source>Alma/SFX Local Collection</source><creator>Korošec, B ; Sova, M ; Turk, S ; Kraševec, N ; Novak, M ; Lah, L ; Stojan, J ; Podobnik, B ; Berne, S ; Zupanec, N ; Bunc, M ; Gobec, S ; Komel, R</creator><creatorcontrib>Korošec, B ; Sova, M ; Turk, S ; Kraševec, N ; Novak, M ; Lah, L ; Stojan, J ; Podobnik, B ; Berne, S ; Zupanec, N ; Bunc, M ; Gobec, S ; Komel, R</creatorcontrib><description>AIMS: CYP53A15, from the sorghum pathogen Cochliobolus lunatus, is involved in detoxification of benzoate, a key intermediate in aromatic compound metabolism in fungi. Because this enzyme is unique to fungi, it is a promising drug target in fungal pathogens of other eukaryotes. METHODS AND RESULTS: In our work, we showed high antifungal activity of seven cinnamic acid derivatives against C. lunatus and two other fungi, Aspergillus niger and Pleurotus ostreatus. To elucidate the mechanism of action of cinnamic acid derivatives with the most potent antifungal properties, we studied the interactions between these compounds and the active site of C. lunatus cytochrome P450, CYP53A15. CONCLUSION: We demonstrated that cinnamic acid and at least four of the 42 tested derivatives inhibit CYP53A15 enzymatic activity. SIGNIFICANCE AND IMPACT OF THE STUDY: By identifying selected derivatives of cinnamic acid as possible antifungal drugs, and CYP53 family enzymes as their targets, we revealed a potential inhibitor‐target system for antifungal drug development.</description><identifier>ISSN: 1364-5072</identifier><identifier>EISSN: 1365-2672</identifier><identifier>DOI: 10.1111/jam.12417</identifier><identifier>PMID: 24314266</identifier><identifier>CODEN: JAMIFK</identifier><language>eng</language><publisher>Oxford: Published for the Society for Applied Bacteriology by Blackwell Science</publisher><subject>active sites ; antifungal activity ; antifungal agents ; Antifungal Agents - chemistry ; Antifungal Agents - metabolism ; Antifungal Agents - pharmacology ; antifungal properties ; Ascomycota - drug effects ; Aspergillus niger ; Benzoate 4-Monooxygenase - antagonists & inhibitors ; Benzoate 4-Monooxygenase - chemistry ; Benzoate 4-Monooxygenase - metabolism ; Biological and medical sciences ; Catalytic Domain ; Cinnamates - chemistry ; Cinnamates - metabolism ; Cinnamates - pharmacology ; cinnamic acid ; Cochliobolus lunatus ; Curvularia lunata ; CYP53 inhibition ; cytochrome P-450 ; cytochrome P450, benzoate 4‐monooxygenase ; drugs ; enzyme activity ; Enzyme Inhibitors - chemistry ; Enzyme Inhibitors - metabolism ; Enzyme Inhibitors - pharmacology ; enzymes ; Eukaryotes ; eukaryotic cells ; Fundamental and applied biological sciences. Psychology ; Fungi ; Fungi - enzymology ; mechanism of action ; metabolism ; Microbiology ; pathogens ; Pharmacology ; Plant pathology ; Pleurotus - drug effects ; Pleurotus ostreatus ; potential antifungal drugs</subject><ispartof>Journal of applied microbiology, 2014-04, Vol.116 (4), p.955-966</ispartof><rights>2013 The Society for Applied Microbiology</rights><rights>2015 INIST-CNRS</rights><rights>2013 The Society for Applied Microbiology.</rights><rights>Copyright © 2014 The Society for Applied Microbiology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4077-5137232f50ac24147f8a5c340a57ce40f5f28b64821bc267c302dce263c12f33</citedby><cites>FETCH-LOGICAL-c4077-5137232f50ac24147f8a5c340a57ce40f5f28b64821bc267c302dce263c12f33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28283568$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24314266$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Korošec, B</creatorcontrib><creatorcontrib>Sova, M</creatorcontrib><creatorcontrib>Turk, S</creatorcontrib><creatorcontrib>Kraševec, N</creatorcontrib><creatorcontrib>Novak, M</creatorcontrib><creatorcontrib>Lah, L</creatorcontrib><creatorcontrib>Stojan, J</creatorcontrib><creatorcontrib>Podobnik, B</creatorcontrib><creatorcontrib>Berne, S</creatorcontrib><creatorcontrib>Zupanec, N</creatorcontrib><creatorcontrib>Bunc, M</creatorcontrib><creatorcontrib>Gobec, S</creatorcontrib><creatorcontrib>Komel, R</creatorcontrib><title>Antifungal activity of cinnamic acid derivatives involves inhibition of benzoate 4‐hydroxylase (CYP53)</title><title>Journal of applied microbiology</title><addtitle>J Appl Microbiol</addtitle><description>AIMS: CYP53A15, from the sorghum pathogen Cochliobolus lunatus, is involved in detoxification of benzoate, a key intermediate in aromatic compound metabolism in fungi. Because this enzyme is unique to fungi, it is a promising drug target in fungal pathogens of other eukaryotes. METHODS AND RESULTS: In our work, we showed high antifungal activity of seven cinnamic acid derivatives against C. lunatus and two other fungi, Aspergillus niger and Pleurotus ostreatus. To elucidate the mechanism of action of cinnamic acid derivatives with the most potent antifungal properties, we studied the interactions between these compounds and the active site of C. lunatus cytochrome P450, CYP53A15. CONCLUSION: We demonstrated that cinnamic acid and at least four of the 42 tested derivatives inhibit CYP53A15 enzymatic activity. SIGNIFICANCE AND IMPACT OF THE STUDY: By identifying selected derivatives of cinnamic acid as possible antifungal drugs, and CYP53 family enzymes as their targets, we revealed a potential inhibitor‐target system for antifungal drug development.</description><subject>active sites</subject><subject>antifungal activity</subject><subject>antifungal agents</subject><subject>Antifungal Agents - chemistry</subject><subject>Antifungal Agents - metabolism</subject><subject>Antifungal Agents - pharmacology</subject><subject>antifungal properties</subject><subject>Ascomycota - drug effects</subject><subject>Aspergillus niger</subject><subject>Benzoate 4-Monooxygenase - antagonists & inhibitors</subject><subject>Benzoate 4-Monooxygenase - chemistry</subject><subject>Benzoate 4-Monooxygenase - metabolism</subject><subject>Biological and medical sciences</subject><subject>Catalytic Domain</subject><subject>Cinnamates - chemistry</subject><subject>Cinnamates - metabolism</subject><subject>Cinnamates - pharmacology</subject><subject>cinnamic acid</subject><subject>Cochliobolus lunatus</subject><subject>Curvularia lunata</subject><subject>CYP53 inhibition</subject><subject>cytochrome P-450</subject><subject>cytochrome P450, benzoate 4‐monooxygenase</subject><subject>drugs</subject><subject>enzyme activity</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Enzyme Inhibitors - metabolism</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>enzymes</subject><subject>Eukaryotes</subject><subject>eukaryotic cells</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fungi</subject><subject>Fungi - enzymology</subject><subject>mechanism of action</subject><subject>metabolism</subject><subject>Microbiology</subject><subject>pathogens</subject><subject>Pharmacology</subject><subject>Plant pathology</subject><subject>Pleurotus - drug effects</subject><subject>Pleurotus ostreatus</subject><subject>potential antifungal drugs</subject><issn>1364-5072</issn><issn>1365-2672</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp1kM1OFTEUxxsDEUQXvgBMYkxkMdDvzvbmxg8IRBNx4ao502m5vZnbYjv36rjiEXhGn8TCXGRlNz1pf-f8c34IvSb4hJRzuoTVCaGcqGdonzApaioV3XmoeS2wonvoRc5LjAnDQj5He5QzwqmU-2gxC4N363ANfQVm8Bs_jFV0lfEhwMqb8ui7qrPJb6D82lz5sIn9VCx86wcfw31Da8PvCIOt-J_bu8XYpfhr7CHb6t38-xfBjl-iXQd9tq-29wG6-vD-av6pvvj88Ww-u6gNx0rVgjBFGXUCgykbceUaEIZxDEIZy7ETjjat5A0lrSlrGoZpZyyVzBDqGDtAb6axNyn-WNs86GVcp1ASNSkmlCoCcKGOJ8qkmHOyTt8kv4I0aoL1vVJdlOoHpYU93E5ctyvb_SMfHRbg7RaAbKB3CYLx-YlraMOEbAp3OnE_fW_H_yfq89nlY_TR1OEgarhOZeq3rxSXRXAxI3HD_gKvwZXg</recordid><startdate>201404</startdate><enddate>201404</enddate><creator>Korošec, B</creator><creator>Sova, M</creator><creator>Turk, S</creator><creator>Kraševec, N</creator><creator>Novak, M</creator><creator>Lah, L</creator><creator>Stojan, J</creator><creator>Podobnik, B</creator><creator>Berne, S</creator><creator>Zupanec, N</creator><creator>Bunc, M</creator><creator>Gobec, S</creator><creator>Komel, R</creator><general>Published for the Society for Applied Bacteriology by Blackwell Science</general><general>Blackwell</general><general>Oxford University Press</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TM</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>201404</creationdate><title>Antifungal activity of cinnamic acid derivatives involves inhibition of benzoate 4‐hydroxylase (CYP53)</title><author>Korošec, B ; Sova, M ; Turk, S ; Kraševec, N ; Novak, M ; Lah, L ; Stojan, J ; Podobnik, B ; Berne, S ; Zupanec, N ; Bunc, M ; Gobec, S ; Komel, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4077-5137232f50ac24147f8a5c340a57ce40f5f28b64821bc267c302dce263c12f33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>active sites</topic><topic>antifungal activity</topic><topic>antifungal agents</topic><topic>Antifungal Agents - chemistry</topic><topic>Antifungal Agents - metabolism</topic><topic>Antifungal Agents - pharmacology</topic><topic>antifungal properties</topic><topic>Ascomycota - drug effects</topic><topic>Aspergillus niger</topic><topic>Benzoate 4-Monooxygenase - antagonists & inhibitors</topic><topic>Benzoate 4-Monooxygenase - chemistry</topic><topic>Benzoate 4-Monooxygenase - metabolism</topic><topic>Biological and medical sciences</topic><topic>Catalytic Domain</topic><topic>Cinnamates - chemistry</topic><topic>Cinnamates - metabolism</topic><topic>Cinnamates - pharmacology</topic><topic>cinnamic acid</topic><topic>Cochliobolus lunatus</topic><topic>Curvularia lunata</topic><topic>CYP53 inhibition</topic><topic>cytochrome P-450</topic><topic>cytochrome P450, benzoate 4‐monooxygenase</topic><topic>drugs</topic><topic>enzyme activity</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Enzyme Inhibitors - metabolism</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>enzymes</topic><topic>Eukaryotes</topic><topic>eukaryotic cells</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fungi</topic><topic>Fungi - enzymology</topic><topic>mechanism of action</topic><topic>metabolism</topic><topic>Microbiology</topic><topic>pathogens</topic><topic>Pharmacology</topic><topic>Plant pathology</topic><topic>Pleurotus - drug effects</topic><topic>Pleurotus ostreatus</topic><topic>potential antifungal drugs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Korošec, B</creatorcontrib><creatorcontrib>Sova, M</creatorcontrib><creatorcontrib>Turk, S</creatorcontrib><creatorcontrib>Kraševec, N</creatorcontrib><creatorcontrib>Novak, M</creatorcontrib><creatorcontrib>Lah, L</creatorcontrib><creatorcontrib>Stojan, J</creatorcontrib><creatorcontrib>Podobnik, B</creatorcontrib><creatorcontrib>Berne, S</creatorcontrib><creatorcontrib>Zupanec, N</creatorcontrib><creatorcontrib>Bunc, M</creatorcontrib><creatorcontrib>Gobec, S</creatorcontrib><creatorcontrib>Komel, R</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Journal of applied microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Korošec, B</au><au>Sova, M</au><au>Turk, S</au><au>Kraševec, N</au><au>Novak, M</au><au>Lah, L</au><au>Stojan, J</au><au>Podobnik, B</au><au>Berne, S</au><au>Zupanec, N</au><au>Bunc, M</au><au>Gobec, S</au><au>Komel, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antifungal activity of cinnamic acid derivatives involves inhibition of benzoate 4‐hydroxylase (CYP53)</atitle><jtitle>Journal of applied microbiology</jtitle><addtitle>J Appl Microbiol</addtitle><date>2014-04</date><risdate>2014</risdate><volume>116</volume><issue>4</issue><spage>955</spage><epage>966</epage><pages>955-966</pages><issn>1364-5072</issn><eissn>1365-2672</eissn><coden>JAMIFK</coden><abstract>AIMS: CYP53A15, from the sorghum pathogen Cochliobolus lunatus, is involved in detoxification of benzoate, a key intermediate in aromatic compound metabolism in fungi. Because this enzyme is unique to fungi, it is a promising drug target in fungal pathogens of other eukaryotes. METHODS AND RESULTS: In our work, we showed high antifungal activity of seven cinnamic acid derivatives against C. lunatus and two other fungi, Aspergillus niger and Pleurotus ostreatus. To elucidate the mechanism of action of cinnamic acid derivatives with the most potent antifungal properties, we studied the interactions between these compounds and the active site of C. lunatus cytochrome P450, CYP53A15. CONCLUSION: We demonstrated that cinnamic acid and at least four of the 42 tested derivatives inhibit CYP53A15 enzymatic activity. SIGNIFICANCE AND IMPACT OF THE STUDY: By identifying selected derivatives of cinnamic acid as possible antifungal drugs, and CYP53 family enzymes as their targets, we revealed a potential inhibitor‐target system for antifungal drug development.</abstract><cop>Oxford</cop><pub>Published for the Society for Applied Bacteriology by Blackwell Science</pub><pmid>24314266</pmid><doi>10.1111/jam.12417</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1364-5072 |
ispartof | Journal of applied microbiology, 2014-04, Vol.116 (4), p.955-966 |
issn | 1364-5072 1365-2672 |
language | eng |
recordid | cdi_proquest_journals_1507770560 |
source | Alma/SFX Local Collection |
subjects | active sites antifungal activity antifungal agents Antifungal Agents - chemistry Antifungal Agents - metabolism Antifungal Agents - pharmacology antifungal properties Ascomycota - drug effects Aspergillus niger Benzoate 4-Monooxygenase - antagonists & inhibitors Benzoate 4-Monooxygenase - chemistry Benzoate 4-Monooxygenase - metabolism Biological and medical sciences Catalytic Domain Cinnamates - chemistry Cinnamates - metabolism Cinnamates - pharmacology cinnamic acid Cochliobolus lunatus Curvularia lunata CYP53 inhibition cytochrome P-450 cytochrome P450, benzoate 4‐monooxygenase drugs enzyme activity Enzyme Inhibitors - chemistry Enzyme Inhibitors - metabolism Enzyme Inhibitors - pharmacology enzymes Eukaryotes eukaryotic cells Fundamental and applied biological sciences. Psychology Fungi Fungi - enzymology mechanism of action metabolism Microbiology pathogens Pharmacology Plant pathology Pleurotus - drug effects Pleurotus ostreatus potential antifungal drugs |
title | Antifungal activity of cinnamic acid derivatives involves inhibition of benzoate 4‐hydroxylase (CYP53) |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T12%3A25%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antifungal%20activity%20of%20cinnamic%20acid%20derivatives%20involves%20inhibition%20of%20benzoate%204%E2%80%90hydroxylase%20(CYP53)&rft.jtitle=Journal%20of%20applied%20microbiology&rft.au=Koro%C5%A1ec,%20B&rft.date=2014-04&rft.volume=116&rft.issue=4&rft.spage=955&rft.epage=966&rft.pages=955-966&rft.issn=1364-5072&rft.eissn=1365-2672&rft.coden=JAMIFK&rft_id=info:doi/10.1111/jam.12417&rft_dat=%3Cproquest_cross%3E3247834631%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4077-5137232f50ac24147f8a5c340a57ce40f5f28b64821bc267c302dce263c12f33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1507770560&rft_id=info:pmid/24314266&rfr_iscdi=true |